Hello and Welcome to Patientsville.com, Your Source for all MERCAPTOPURINE information. We are dedicated to provide You with MERCAPTOPURINE safety information. Learn about MERCAPTOPURINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MERCAPTOPURINE Safety Reports
Total MERCAPTOPURINE reports: 40.MERCAPTOPURINE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 29.
Take MERCAPTOPURINE Side Effects Survey or Share Your MERCAPTOPURINE Story. Read More Here.
Physician from UNITED STATES reported MERCAPTOPURINE problem on Jan 04, 2007. Male patient was diagnosed with leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: ascites, atelectasis, pancreatic necrosis, pancreatitis, pleural effusion. MERCAPTOPURINE dosage: 100 MG DAILY. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from ITALY on Dec 26, 2006. Female patient, 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, electroencephalogram abnormal, hemiparesis, hypokalaemia. MERCAPTOPURINE dosage: 50 MG/M^2/ 1X PER 1 DAY. During the same period patient was treated with DELORAZEPAM, METHOTREXATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported MERCAPTOPURINE problem on Jan 03, 2007. Female patient, 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hemiparesis, hypokalaemia. MERCAPTOPURINE dosage: 50 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE, DELORAZEPAM. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Physician from UNITED STATES on Mar 06, 2007. Male patient, 16 years of age, weighting 105.0 lb, was diagnosed with leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancreatic necrosis, pancreatitis. MERCAPTOPURINE dosage: 100 MG (50 MG X 2) ONCE DAY PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Apr 05, 2007. Female patient, weighting 85.98 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: anaemia, hepatic failure, hepatic necrosis, influenza. MERCAPTOPURINE dosage: 4300 MG. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Pharmacist from UNITED STATES on Apr 12, 2007. Male patient, child 7 years of age, weighting 59.52 lb, was diagnosed with acute lymphocytic leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: rash maculo-papular, rash pruritic. MERCAPTOPURINE dosage: 75 MG DAILY PO. During the same period patient was treated with METHOTREXATE. Patient recovered.
Pharmacist from UNITED STATES reported MERCAPTOPURINE problem on May 16, 2007. Female patient, 72 years of age, weighting 149.9 lb, was diagnosed with polymyositis and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, white blood cell count decreased. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with LOPRESSOR, NOVOLIN R, CYMBALTA, ASPIRIN, CLONIDINE, PLAVIX, DIGOXIN, FOLIC ACID. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from on May 30, 2007. Female patient, 23 years of age, weighting 127.9 lb, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pyrexia. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with MESALAMINE, PREDNISOLONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on June 28, 2007. Male patient, weighting 220.5 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, nausea, neutropenia, pyrexia, vomiting. MERCAPTOPURINE dosage: 3548 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE, AUGMENTIN, ACYCLOVIR, AFRIN, LOTENSIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from CANADA on July 06, 2006. Male patient, 39 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage, gastrointestinal ulcer, stomach discomfort, white blood cell count decreased. MERCAPTOPURINE dosage: 50 MILLIGRAM ORAL. Patient recovered.
Consumer or non-health professional from CANADA reported MERCAPTOPURINE problem on July 26, 2006. Male patient, 39 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, gastrointestinal haemorrhage, gastrointestinal ulcer, headache, pharyngolaryngeal pain, white blood cell count decreased. MERCAPTOPURINE dosage: 50 MILLIGRAM ORAL. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2006. Female patient, weighting 179.9 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aggression, alanine aminotransferase increased, ammonia increased, amnesia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dizziness. MERCAPTOPURINE dosage: 3100 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, NEURONTIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Sept 11, 2006. Female patient, weighting 172.4 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dehydration, gallbladder disorder, gastroenteritis viral, ocular icterus. MERCAPTOPURINE dosage: 11449 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2006. Male patient, 29 years of age, was diagnosed with proctitis ulcerative and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, diffuse large b-cell lymphoma, epstein-barr virus antigen positive, irritable bowel syndrome, metastases to bone, metastases to lymph nodes, metastases to the mediastinum. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, PREDNISONE, REMICADE, STEROID. Patient recovered.
Pharmacist from UNITED STATES reported MERCAPTOPURINE problem on Sept 19, 2006. Male patient, 82 years of age, weighting 127.9 lb, was diagnosed with colitis ulcerative, crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood albumin decreased, duodenal ulcer, duodenal ulcer haemorrhage, gastrointestinal haemorrhage, haematocrit decreased, hypotension, intestinal perforation, leukocytosis. MERCAPTOPURINE dosage: 50 MG DAILY PO. During the same period patient was treated with MESALAMINE SA, PREDNISONE, OMEPRAZOLE, RANITIDINE, CIPROFLOXACIN, METRONIDAZOLE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, weighting 172.4 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, cholelithiasis, dehydration, diarrhoea. MERCAPTOPURINE dosage: 11449 MG SEE IMAGE. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, VINCRISTINE SULPHATE. Patient recovered.
Consumer or non-health professional from reported MERCAPTOPURINE problem on Oct 05, 2006. Male patient, child 3 years of age, was diagnosed with acute lymphocytic leukaemia (in remission) and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood glucose decreased, blood ph decreased, febrile neutropenia, food craving, hyperhidrosis. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, PREDNISOLONE, LEUCOVORIN RESCUE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Male patient, weighting 32.85 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased. MERCAPTOPURINE dosage: 854.25 MG. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported MERCAPTOPURINE problem on Oct 26, 2006. Female patient, 25 years of age, weighting 167.6 lb, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. MERCAPTOPURINE dosage: 50 MG DAILY PO. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, weighting 172.4 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, cholelithiasis, diarrhoea, haemoglobin decreased, hepatomegaly, pain, pain of skin, platelet count decreased, prothrombin time prolonged. MERCAPTOPURINE dosage: 11449 MG. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, VINCRISTINE SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Oct 30, 2006. Female patient was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. MERCAPTOPURINE dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from on Nov 07, 2006. Male patient, child 7 years of age, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, coagulation factor v level decreased, international normalised ratio increased, neutropenia, prothrombin time prolonged. MERCAPTOPURINE dosage: 75 MG/M2/DAY. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE, ASPARAGINASE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Nov 15, 2006. Female patient, weighting 86.64 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: sepsis. MERCAPTOPURINE dosage: 15960 MG PO. During the same period patient was treated with METHOTREXATE, THIOGUANINE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 11/09/2006.
MERCAPTOPURINE problem was reported by a Pharmacist from UNITED STATES on Nov 27, 2006. Female patient, 15 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. MERCAPTOPURINE dosage: 7.5 MG ,1.5 TABS DAILY PO. During the same period patient was treated with FLAGYL, ASACOL, URSODIOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Dec 18, 2006. Female patient, weighting 86.64 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood glucose increased. MERCAPTOPURINE dosage: 15960 MG. During the same period patient was treated with METHOTREXATE, THIOGUANINE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Health Professional from UNITED STATES on Dec 18, 2006. Female patient was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, sepsis. MERCAPTOPURINE dosage: 100 MG (100 MG, 1 IN 1 D). During the same period patient was treated with AZATHIOPRINE. Patient died.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on July 02, 2007. Male patient, weighting 31.75 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood glucose decreased, blood insulin decreased, blood pressure diastolic decreased, gait disturbance, haemoglobin decreased, heart rate increased, hyperhidrosis, hypothermia. MERCAPTOPURINE dosage: 2800 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, weighting 229.3 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hypotension, meniscus lesion, osteoarthritis. MERCAPTOPURINE dosage: 4620 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, ALLOPURINOL, BACTRIM DS, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on July 30, 2007. Male patient, child 11 years of age, weighting 110.0 lb, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: psoriasis. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with ASACOL. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Male patient, weighting 139.1 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, blood culture positive, cardiac arrest, hypogammaglobulinaemia, neutropenia, nocardiosis, pneumocystis jiroveci infection, pneumonitis, pneumothorax. MERCAPTOPURINE dosage: 1300 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported MERCAPTOPURINE problem on Aug 14, 2007. Female patient, 56 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with NORVASC, LEXAPRO, TRAMADOL, ASPIRIN, QUINIC, AMBIEN, BENADRYL. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 13, 2007. Male patient, weighting 139.1 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, blood culture positive, cardiac arrest, hypogammaglobulinaemia, neutropenia, nocardiosis, pneumocystis jiroveci infection, pneumonia fungal, pneumonitis. MERCAPTOPURINE dosage: 1300 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported MERCAPTOPURINE problem on Aug 21, 2007. Male patient, 14 years of age, weighting 154.0 lb, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. MERCAPTOPURINE dosage: 50MG QD PO. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from on Aug 21, 2007. Male patient, 66 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: cough, diabetes mellitus, dyspnoea, hypoxia, influenza like illness, interstitial lung disease, myalgia, pulmonary toxicity. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISONE, MESALAMINE, INFLIXIMAB, LANSOPRAZOLE, FLOMAX, ALPRAZOLAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Aug 30, 2007. Male patient, weighting 233.7 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, chills, fatigue, liver function test abnormal, staphylococcal infection. MERCAPTOPURINE dosage: 5250 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, LEUCOVORIN CALCIUM, BACTRIM DS, PROTONIX. Patient was hospitalized. Patient recovered.
MERCAPTOPURINE problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Male patient, 66 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: diffuse alveolar damage, interstitial lung disease, myalgia, pulmonary toxicity, respiratory failure. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISONE, LANSOPRAZOLE, TAMSULOSIN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Aug 21, 2007. Male patient was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: pregnancy of partner. MERCAPTOPURINE dosage: 50 MG; ORAL. Patient recovered.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from on Sept 11, 2007. Male patient, 32 years of age, was diagnosed with crohn's disease, abdominal pain, systemic antifungal treatment, infection and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal sepsis, gallbladder necrosis, gastric perforation, gastrointestinal haemorrhage, liver abscess, mucormycosis, multi-organ failure, pneumoperitoneum. MERCAPTOPURINE dosage: unknown. During the same period patient was treated with INFLIXIMAB, CORTICOSTEROIDS, ABELCET, BROAD. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Sept 05, 2007. Male patient, 32 years of age, was diagnosed with crohn's disease and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal sepsis, candidiasis, enterococcal infection, gallbladder necrosis, gastric perforation, gastrointestinal haemorrhage, haemodynamic instability, large intestine perforation. MERCAPTOPURINE dosage: 75 MG (75 MG, 1 IN 1 D). During the same period patient was treated with INFLIXIMAB, CORTICOSTEROIDS. Patient was hospitalized. Patient died.
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient, weighting 126.3 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic enzyme increased, hypokalaemia. MERCAPTOPURINE dosage: 100 MG. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.